CLDX
$27.53-4.84%
Celldex Therapeutics Inc.Stock · HealthcareRussell 2000 0.09%Nasdaq Composite 0.008%Russell 3000 0.004%US Stock Market 0.004%
Celldex Therapeutics Inc. monthly returns
Celldex Therapeutics Inc. has averaged 2.10% per month, positive in 45% of months. Month-by-month returns for Celldex Therapeutics Inc. (CLDX) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+2.1%
478 months
Best month
+386.9%
Jun 2020
Worst month
-68.2%
Apr 2018
Positive months
45%
of all months
Celldex Therapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -15.1% | |
| Sep 2026 | -18.2% | |
| Aug 2026 | +4.1% | |
| Jul 2026 | +2.3% | |
| Jun 2026 | +18.4% | |
| May 2026 | -4.4% | |
| Apr 2026 | +3.7% | |
| Mar 2026 | +5.4% | |
| Feb 2026 | +22.3% | |
| Jan 2026 | -9.4% | |
| Dec 2025 | +0.5% | |
| Nov 2025 | +1.1% | |
| Oct 2025 | +3.3% | |
| Sep 2025 | +17.2% | |
| Aug 2025 | +0.5% | |
| Jul 2025 | +8.0% | |
| Jun 2025 | +2.9% | |
| May 2025 | -5.0% | |
| Apr 2025 | +14.8% | |
| Mar 2025 | -11.8% | |
| Feb 2025 | -16.0% | |
| Jan 2025 | -3.1% | |
| Dec 2024 | -7.9% | |
| Nov 2024 | +5.3% | |
| Oct 2024 | -23.3% | |
| Sep 2024 | -17.8% | |
| Aug 2024 | +8.4% | |
| Jul 2024 | +3.0% | |
| Jun 2024 | +11.1% | |
| May 2024 | -11.0% | |
| Apr 2024 | -10.8% | |
| Mar 2024 | -12.7% | |
| Feb 2024 | +36.5% | |
| Jan 2024 | -11.2% | |
| Dec 2023 | +31.3% | |
| Nov 2023 | +28.4% | |
| Oct 2023 | -14.5% | |
| Sep 2023 | -1.4% | |
| Aug 2023 | -21.1% | |
| Jul 2023 | +4.2% | |
| Jun 2023 | +6.7% | |
| May 2023 | +1.1% | |
| Apr 2023 | -12.6% | |
| Mar 2023 | -15.9% | |
| Feb 2023 | -2.9% | |
| Jan 2023 | -1.1% | |
| Dec 2022 | +20.2% | |
| Nov 2022 | +5.6% | |
| Oct 2022 | +25.0% | |
| Sep 2022 | -7.5% | |
| Aug 2022 | -1.0% | |
| Jul 2022 | +13.9% | |
| Jun 2022 | +14.6% | |
| May 2022 | -23.0% | |
| Apr 2022 | -10.3% | |
| Mar 2022 | +13.9% | |
| Feb 2022 | -3.6% | |
| Jan 2022 | -19.7% | |
| Dec 2021 | +1.4% | |
| Nov 2021 | -10.4% | |
| Oct 2021 | -21.2% | |
| Sep 2021 | +2.5% | |
| Aug 2021 | +20.3% | |
| Jul 2021 | +30.8% | |
| Jun 2021 | +19.6% | |
| May 2021 | -7.8% | |
| Apr 2021 | +47.2% | |
| Mar 2021 | -23.9% | |
| Feb 2021 | +25.3% | |
| Jan 2021 | +23.4% | |
| Dec 2020 | -22.1% | |
| Nov 2020 | +42.0% | |
| Oct 2020 | +6.8% | |
| Sep 2020 | +24.2% | |
| Aug 2020 | +16.0% | |
| Jul 2020 | -20.8% | |
| Jun 2020 | +386.9% | |
| May 2020 | +9.0% | |
| Apr 2020 | +47.6% | |
| Mar 2020 | -36.9% | |
| Feb 2020 | +13.4% | |
| Jan 2020 | +4.0% | |
| Dec 2019 | -7.1% | |
| Nov 2019 | +7.1% | |
| Oct 2019 | +5.2% | |
| Sep 2019 | +0.5% | |
| Aug 2019 | -2.8% | |
| Jul 2019 | -18.7% | |
| Jun 2019 | -11.8% | |
| May 2019 | -16.9% | |
| Apr 2019 | -25.6% | |
| Mar 2019 | -7.5% | |
| Feb 2019 | -30.5% | |
| Jan 2019 | +155.0% | |
| Dec 2018 | -33.3% | |
| Nov 2018 | -3.2% | |
| Oct 2018 | -31.1% | |
| Sep 2018 | -10.0% | |
| Aug 2018 | +6.4% | |
| Jul 2018 | -6.0% | |
| Jun 2018 | -13.8% | |
| May 2018 | -21.6% | |
| Apr 2018 | -68.2% | |
| Mar 2018 | +3.6% | |
| Feb 2018 | -18.5% | |
| Jan 2018 | -2.8% | |
| Dec 2017 | -5.3% | |
| Nov 2017 | +23.0% | |
| Oct 2017 | -14.7% | |
| Sep 2017 | +16.3% | |
| Aug 2017 | +7.4% | |
| Jul 2017 | -7.3% | |
| Jun 2017 | -12.7% | |
| May 2017 | -15.0% | |
| Apr 2017 | -7.8% | |
| Mar 2017 | +2.0% | |
| Feb 2017 | +8.6% | |
| Jan 2017 | -7.9% | |
| Dec 2016 | -7.1% | |
| Nov 2016 | +21.0% |
Monthly total return (since Nov 2021)#
-30%-20%-10%0%10%20%30%
Nov 2021-10%
Dec 2021+1.4%
Jan 2022-20%2022
Feb 2022-3.6%
Mar 2022+14%
Apr 2022-10%
May 2022-23%
Jun 2022+15%
Jul 2022+14%
Aug 2022-1.0%
Sep 2022-7.5%
Oct 2022+25%
Nov 2022+5.6%
Dec 2022+20%
Jan 2023-1.1%2023
Feb 2023-2.9%
Mar 2023-16%
Apr 2023-13%
May 2023+1.1%
Jun 2023+6.7%
Jul 2023+4.2%
Aug 2023-21%
Sep 2023-1.4%
Oct 2023-15%
Nov 2023+28%
Dec 2023+31%
Jan 2024-11%2024
Feb 2024+36%
Mar 2024-13%
Apr 2024-11%
May 2024-11%
Jun 2024+11%
Jul 2024+3.0%
Aug 2024+8.4%
Sep 2024-18%
Oct 2024-23%
Nov 2024+5.3%
Dec 2024-7.9%
Jan 2025-3.1%2025
Feb 2025-16%
Mar 2025-12%
Apr 2025+15%
May 2025-5.0%
Jun 2025+2.9%
Jul 2025+8.0%
Aug 2025+0.46%
Sep 2025+17%
Oct 2025+3.3%
Nov 2025+1.1%
Dec 2025+0.52%
Jan 2026-9.4%2026
Feb 2026+22%
Mar 2026+5.4%
Apr 2026+3.7%
May 2026-4.4%
Jun 2026+18%
Jul 2026+2.3%
Aug 2026+4.1%
Sep 2026-18%
Oct 2026-15%
Celldex Therapeutics Inc. returns by calendar month#
Every month of every year since 1987, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -15.06% — 30th of 40 Octobers since 1987 at the last close; the average October returned +0.6%.
| Month | −390%0+390% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +12.3% | +3.8% | 55% | +155.0% 2019 | -47.1% 2016 | |
| Feb | -0.4% | -3.2% | 43% | +101.1% 2000 | -58.5% 2002 | |
| Mar | +0.6% | -1.4% | 48% | +51.3% 1991 | -44.4% 2016 | |
| Apr | +0.3% | +1.0% | 50% | +47.6% 2020 | -68.2% 2018 | |
| May | -2.2% | -6.0% | 28% | +81.3% 2003 | -38.4% 2002 | |
| Jun | +15.2% | +2.8% | 53% | +386.9% 2020 | -32.0% 2010 | |
| Jul | -1.2% | -1.5% | 45% | +34.1% 1991 | -38.7% 1996 | |
| Aug | -2.2% | -2.7% | 40% | +49.0% 2000 | -37.0% 2015 | |
| Sep | -2.0% | -4.6% | 33% | +63.1% 2013 | -32.9% 2001 | |
| Oct | +0.6% | +2.0% | 51% | +43.5% 2001 | -35.4% 2013 | |
| Nov | +5.1% | +2.6% | 56% | +49.3% 2015 | -20.8% 1987 | |
| Dec | -0.6% | -1.7% | 46% | +40.0% 1998 | -33.3% 2018 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from CLDX's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Celldex Therapeutics Inc.'s average monthly return?
- Celldex Therapeutics Inc. (CLDX) has averaged about 2.10% per month, positive in roughly 45% of months. The best month was Jun 2020 (+386.9%) and the worst was Apr 2018 (-68.2%).
More on Celldex Therapeutics Inc.
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100